ArticleACS omega2025
Inhibitory Effects and the Potential Mechanism of Phloretin on Animal Fatty Acid Synthase.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fatty acid synthase (FASN), a critical enzyme involved in lipid biosynthesis, is highly expressed in adipocytes and exhibits aberrant activity in diverse human cancers. Phloretin, a natural dihydrochalcone abundant in apple peels, crabapples, strawberries, and pears, has emerged as a potential modulator of FASN activity. This study investigates phloretin's inhibitory effects on FASN and the underlying mechanisms. Biochemical assays revealed that phloretin inhibited FASN in a dose-dependent manner, with a half-maximal inhibitory concentration (IC
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.